Consortium meeting: May 2009 at EMBL, Hamburg
Monday (11.05.09)
Tuesday (12.05.09)
8:30-9:15   Patri Pal Singh (Partner 7) (WP4)
"Identification of novel drugs against tuberculosis"
9:15-10:00 Arrival at EMBL Matthias Ehebauer (Partner 5) (WP4)
“Mycobacterial ACCase: A six-fold redundant set of carboxylases?”
Coffee break
Coffee break
10:30-11:00 Welcome by Piet Herdewijn, Matthias Wilmanns and outline of meeting Yusuf Akhter (Partner 5) (WP4)
“MTB transcription factors“
11:00-11:45 Martin Kögler (Partner 1) (WP1,3)
“Synthesis of potential inhibitors of a novel folate-dependant thymidylate synthase in Mycobacterium tuberculosis

Concluding discussion
Future meetings and reporting guidelines
Project management

11:45-12:30 Varadha Sundaramurthy (Partner 2b) (WP2,4)
“A chemical genomics approach to identify modulators of Mycobacterium phagosome maturation”
Lunch (sandwiches)
Lunch (sandwiches)
13:30-14:15 Elaine Davis, Joanna Houghton (Partner 4) (WP1,2,4)
"UvrD helicases of Mtb and additional genetic contributions"
14:15-15:30 Arush Chhabra (Parner 6) (WP1,2)
“Developing novel inhibitors of lipid biosynthetic pathways”
Coffee break
15:45-16:30 Ram S. Upadhayaya (Partner 8) (WP3)
“Design and synthesis of ATP synthase and FAAL protein inhibitors”
16:30-17:15 Jyoti Chattopadhyaya (Partner 3) (WP3)
“Design and synthesis of inhibitors against Mt UvrD”
17:15-18:00 Arunava Dasgupta (Partner 2a) (WP2,4)
"In vitro and in vivo testing of novel compounds for their antimycobacterial activities"

Title: New Approaches to Target Tuberculosis

Acronym: NATT

Contract number: 222965

EC contribution: 2.994.478 €

Duration: 36 months

Starting date: 01/10/2008

Collaborative project